Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Burkhoff

Showing results (211-220 of 484) with videos related to

Pageof 49
Sort By:
Circulation|May 14, 2003
Use of rapamycin slows progression of cardiac transplantation vasculopathyDonna Mancini, Sean Pinney, Daniel Burkhoff, et al.
Journal of Cardiac Failure|October 7, 2014
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and designWilliam T Abraham, JoAnn Lindenfeld, Vivek Y Reddy, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 20, 2015
Accuracy of the HVAD Pump Flow Estimation AlgorithmCarlos Reyes, Neil Voskoboynikov, Katherine Chorpenning, et al.
Frontiers in Physiology|August 25, 2022
Changes of thoracic duct flow and morphology in an animal model of elevated central venous pressureXiao Lu, Mengjun Wang, Ling Han, et al.
Journal of Cardiac Failure|September 11, 2024
HFSA Scientific Statement: Update on Device Based Therapies in Heart FailureJerry D Estep, Husam M Salah, Samir R Kapadia, et al.
Heart Rhythm|September 21, 2024
Cardiac contractility modulation in heart failure with reduced ejection fraction patients with QRS duration 120-149 ms: Reduction in heart failure hospitalizations and improvement in functional outcomeChristian Fastner, Niraj Varma, Ishu Rao, et al.
Circulation|May 14, 2003
Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failureSteven Reiken, Xander H T Wehrens, John A Vest, et al.
Journal of the American College of Cardiology|March 21, 2007
The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failureStefan Klotz, A H Jan Danser, Robert F Foronjy, et al.
Experimental Physiology|February 29, 2024
Running on empty: Factors underpinning impaired cardiac output reserve in heart failure with preserved ejection fractionPaula Sagmeister, Sebastian Rosch, Karl Fengler, et al.
European Heart Journal|May 15, 2008
First human use of partial left ventricular heart support with the Circulite synergy micro-pump as a bridge to cardiac transplantationBart Meyns, Joris Ector, Filip Rega, et al.
Pageof 49

Showing results (211-220 of 484) with videos related to

Sort By:
Pageof 49
Circulation|May 14, 2003
Use of rapamycin slows progression of cardiac transplantation vasculopathyDonna Mancini, Sean Pinney, Daniel Burkhoff, et al.
Journal of Cardiac Failure|October 7, 2014
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and designWilliam T Abraham, JoAnn Lindenfeld, Vivek Y Reddy, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 20, 2015
Accuracy of the HVAD Pump Flow Estimation AlgorithmCarlos Reyes, Neil Voskoboynikov, Katherine Chorpenning, et al.
Frontiers in Physiology|August 25, 2022
Changes of thoracic duct flow and morphology in an animal model of elevated central venous pressureXiao Lu, Mengjun Wang, Ling Han, et al.
Journal of Cardiac Failure|September 11, 2024
HFSA Scientific Statement: Update on Device Based Therapies in Heart FailureJerry D Estep, Husam M Salah, Samir R Kapadia, et al.
Heart Rhythm|September 21, 2024
Cardiac contractility modulation in heart failure with reduced ejection fraction patients with QRS duration 120-149 ms: Reduction in heart failure hospitalizations and improvement in functional outcomeChristian Fastner, Niraj Varma, Ishu Rao, et al.
Circulation|May 14, 2003
Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failureSteven Reiken, Xander H T Wehrens, John A Vest, et al.
Journal of the American College of Cardiology|March 21, 2007
The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failureStefan Klotz, A H Jan Danser, Robert F Foronjy, et al.
Experimental Physiology|February 29, 2024
Running on empty: Factors underpinning impaired cardiac output reserve in heart failure with preserved ejection fractionPaula Sagmeister, Sebastian Rosch, Karl Fengler, et al.
European Heart Journal|May 15, 2008
First human use of partial left ventricular heart support with the Circulite synergy micro-pump as a bridge to cardiac transplantationBart Meyns, Joris Ector, Filip Rega, et al.
Pageof 49